Santarus taps Ventiv force for Zegerid

Share this article:
Specialty pharma company Santarus has hired 140 sales reps from contract sales firm inVentiv Commercial Services to bolster efforts behind its heartburn treatment Zegerid.

Santarus expects the new sales reps to be trained and in place by early 2007, both companies said in a joint news release.

At press time, Santarus, along with co-promotion partner Otsuka America Pharmaceutical, deployed a Zegerid sales force of 370 members to promote Zegerid.

“We believe the additional sales representatives will significantly increase our call frequency and share of voice with the 26,000 high prescribing PPI physicians we currently target,” said Santarus CEO Gerald Proehl in a statement.

Zegerid received its fist FDA approval, for a powder for suspension formulation, in 2004. Capsules received approval in February 2006, followed by chewable tablets in March 2006.

Santarus and inVentiv Commercial Services have been working together since the
August 2004 launch of Zegerid.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.